Axcella Health Inc (AXLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,389 | -3,976 | -81,186 | -58,186 | -40,345 |
| Depreciation Amortization | 21 | 11 | 412 | 290 | 159 |
| Accounts payable and accrued liabilities | 3,689 | 3,443 | 382 | -680 | -137 |
| Other Working Capital | -1,522 | -1,235 | 3,164 | 255 | 2,154 |
| Other Operating Activity | -3,560 | -3,348 | 7,640 | 4,271 | 2,640 |
| Operating Cash Flow | $-8,761 | $-5,105 | $-69,588 | $-54,050 | $-35,529 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 31,349 | 31,349 | 20,974 |
| PPE Investments | 525 | 525 | -426 | -407 | -202 |
| Investing Cash Flow | $525 | $525 | $30,923 | $30,942 | $20,772 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 5,926 | 6,000 | N/A |
| Debt Repayment | -27 | -27 | -175 | -140 | -93 |
| Common Stock Issued | N/A | N/A | 53,677 | 25,521 | 25,546 |
| Other Financing Activity | 0 | 0 | -27,190 | -6,422 | -193 |
| Financing Cash Flow | $-27 | $-27 | $32,238 | $24,959 | $25,260 |
| Beginning Cash Position | 17,147 | 17,147 | 23,574 | 23,574 | 23,574 |
| End Cash Position | 8,884 | 12,540 | 17,147 | 25,425 | 34,077 |
| Net Cash Flow | $-8,263 | $-4,607 | $-6,427 | $1,851 | $10,503 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,761 | -5,105 | -69,588 | -54,050 | -35,529 |
| Capital Expenditure | N/A | N/A | -426 | -407 | -202 |
| Free Cash Flow | -8,761 | -5,105 | -70,014 | -54,457 | -35,731 |